The scientific community is carefully watching the development of Trontinemab, a experimental treatment showing remarkable results in initial clinical trials . The therapy targets toxic tau , a https://elijahmslz323192.mpeblog.com/73570229/trontinemab-a-emerging-breakthrough-for-alzheimer-s